<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02218515</url>
  </required_header>
  <id_info>
    <org_study_id>SAG-C-DRP-090909-0288</org_study_id>
    <nct_id>NCT02218515</nct_id>
  </id_info>
  <brief_title>Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft</brief_title>
  <official_title>Evaluation of Gingival Crevicular Fluid Transforming Growth Factor-β1 Level After Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haner Direskeneli, Prof</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Marmara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aimed to evaluate the effects of enamel matrix derivatives either alone or
      combined with autogenous bone graft applied to intrabony defects in chronic periodontitis
      patients on clinical/radiographic parameters and gingival crevicular fluid transforming
      growth factor-β1 level and, to compare with open flap debridement. Our hypothesis is to test
      whether the use of autogenous bone graft and enamel matrix derivative combination in the
      treatment of intrabony periodontal defects enhance the clinical, radiographic and biochemical
      parameters in comparison to the use of open flap debridement alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study aimed to evaluate the effects of enamel matrix derivatives (EMD) either
      alone or combined with autogenous bone graft (ABG) applied to intrabony defects in chronic
      periodontitis patients on clinical/radiographic parameters and gingival crevicular fluid
      (GCF) transforming growth factor-β1 (TGF-β1) level and, to compare with open flap debridement
      (OFD). A total of 30 deep intrabony defects in 12 patients were randomly treated with EMD+ABG
      (Combination group), EMD alone (EMD group) or OFD (Control group). Clinical parameters
      including plaque index, gingival index, bleeding on probing, probing depth, relative
      attachment level and recession were recorded at baseline and 6 months post-surgery. Intrabony
      defect fill percentage was calculated on the standardized radiographs. TGF-β1 level was
      evaluated in GCF just before surgery and 7, 14, 30, 90, 180 days after surgery using ELISA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Attachment Gain</measure>
    <time_frame>6 months after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gingival crevicular fluid TGF-β1 level</measure>
    <time_frame>1 week, 2 weeks, 4 weeks, 12 weeks and 72 weeks after surgery</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Plaque index</measure>
    <time_frame>Baseline and 6 months post-surgery.</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Gingival index</measure>
    <time_frame>Baseline and 6 months post-surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>Baseline and 6 months post-surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Probing depth</measure>
    <time_frame>Baseline and 6 months post-surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Relative attachment level</measure>
    <time_frame>Baseline and 6 months post-surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Recession</measure>
    <time_frame>Baseline and 6 months post-surgery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Intrabony defect fill percentage</measure>
    <time_frame>Baseline and 6 months post-surgery</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Periodontal Bone Loss</condition>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Open Flap Debridement</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Open Flap Debridement (Control Group)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enamel Matrix Derivative</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open Flap Debridement+EmdogainⓇ(Enamel Matrix Derivative)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Enamel Matrix Derivative+Autogenous Bone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open Flap Debridement+EmdogainⓇ(Enamel Matrix Derivative)+Autogenous Bone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Flap Debridement</intervention_name>
    <description>Open Flap Debridement (Control Group)</description>
    <arm_group_label>Open Flap Debridement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>EmdogainⓇ(Enamel Matrix Derivative)</intervention_name>
    <description>Open Flap Debridement+Enamel Matrix Derivative</description>
    <arm_group_label>Enamel Matrix Derivative</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>EmdogainⓇEnamel Matrix Derivative+Autogenous Bone</intervention_name>
    <description>Open Flap Debridement+EmdogainⓇ(Enamel Matrix Derivative)+Autogenous Bone</description>
    <arm_group_label>Enamel Matrix Derivative+Autogenous Bone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        (a) no systemic diseases as diabetes mellitus or cardiovascular diseases that
        contraindicated periodontal surgery and could influence the outcome of the therapy; (b) no
        smoking (c) no medications affecting periodontal tissues; (d) no pregnancy or lactation;
        (e) a good level of oral hygiene (plaque index &lt; 1, and full mouth bleeding on probing
        score &lt;20% after initial periodontal treatment), (f) compliance with the maintenance
        programme and (g) presence of at least one intra-bony defect with a probing depth ≥6 mm,
        radiographic depth of the defect ≥3 mm as detected on the radiographs.

        Exclusion Criteria:

        (a) pregnancy or lactating, (b) required an antibiotic premedication, (c) received
        antibiotic treatment in the previous 6 months, (d) smokers, (e) whose tooth had inadequate
        amount of attached keratinized gingiva (&lt;1mm)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>32 Years</minimum_age>
    <maximum_age>57 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ömer Birkan Ağralı, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Marmara University Faculty of Dentistry, Department of Periodontology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bahar Kuru, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Marmara University, Faculty of Dentistry, Department of Periodontology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Leyla Kuru, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Marmara University, Faculty of Dentistry, Department of Periodontology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Marmara University Faculty of Dentistry, Department of Periodontology</name>
      <address>
        <city>İstanbul</city>
        <state>Şişli/Nişantaşı</state>
        <zip>34365</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2014</study_first_submitted>
  <study_first_submitted_qc>August 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2014</study_first_posted>
  <last_update_submitted>August 14, 2014</last_update_submitted>
  <last_update_submitted_qc>August 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Marmara University</investigator_affiliation>
    <investigator_full_name>Haner Direskeneli, Prof</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Autogenous bone graft</keyword>
  <keyword>Chronic periodontitis</keyword>
  <keyword>Enamel matrix derivatives</keyword>
  <keyword>Gingival crevicular fluid</keyword>
  <keyword>Periodontal flap surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
    <mesh_term>Alveolar Bone Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

